MAIA
Price:
$1.3
Market Cap:
$79.04M
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
Industry
Biotechnology
IPO Date
2022-07-28
Stock Exchange
AMEX
Ticker
MAIA
According to MAIA Biotechnology, Inc.’s latest financial reports and current stock price. The company's current ROE is -284.80%. This represents a change of -94.75% compared to the average of -5419.89% of the last 4 quarters.
The mean historical ROE of MAIA Biotechnology, Inc. over the last ten years is -298.56%. The current -284.80% ROE has changed -4.61% with respect to the historical average. Over the past ten years (40 quarters), MAIA's ROE was at its highest in in the March 2024 quarter at 139.94%. The ROE was at its lowest in in the September 2025 quarter at -21365.94%.
Average
-298.56%
Median
-185.35%
Minimum
-4140.83%
Maximum
3.76%
Discovering the peaks and valleys of MAIA Biotechnology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.13%
Maximum Annual ROE = 3.76%
Minimum Annual Increase = -168.46%
Minimum Annual ROE = -4140.83%
| Year | ROE | Change |
|---|---|---|
| 2025 | -942.65% | 47.33% |
| 2024 | -639.81% | -84.55% |
| 2023 | -4140.83% | 2.13% |
| 2022 | -185.35% | 36.10% |
| 2021 | -136.19% | -168.46% |
| 2020 | 198.94% | -94.70% |
The current ROE of MAIA Biotechnology, Inc. (MAIA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1907.76%
5-year avg
-1208.97%
10-year avg
-298.56%
MAIA Biotechnology, Inc.’s ROE is greater than Elutia Inc. (-560.64%), less than Lantern Pharma Inc. (-0.97%), less than BioAtla, Inc. (166.67%), greater than PolyPid Ltd. (-241.96%), greater than RenovoRx, Inc. (-138.61%), greater than Annovis Bio, Inc. (-318.08%), greater than Veru Inc. (-53.43%), greater than Tvardi Therapeutics, Inc. (-64.17%), less than Celularity Inc. (411.46%), less than CalciMedica, Inc. (4.09%),
| Company | ROE | Market cap |
|---|---|---|
| -560.64% | $42.44M | |
| -0.97% | $49.50M | |
| 166.67% | $4.87M | |
| -241.96% | $47.08M | |
| -138.61% | $31.41M | |
| -318.08% | $35.02M | |
| -53.43% | $48.15M | |
| -64.17% | $24.77M | |
| 411.46% | $17.15M | |
| 4.09% | $13.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MAIA Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MAIA Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MAIA Biotechnology, Inc.'s ROE?
How is the ROE calculated for MAIA Biotechnology, Inc. (MAIA)?
What is the highest ROE for MAIA Biotechnology, Inc. (MAIA)?
What is the 3-year average ROE for MAIA Biotechnology, Inc. (MAIA)?
What is the 5-year average ROE for MAIA Biotechnology, Inc. (MAIA)?
How does the current ROE for MAIA Biotechnology, Inc. (MAIA) compare to its historical average?